Company intelligence / Profile preview

KoBioLabs

Seoul, Seoul, South Koreakobiolabs.com ↗
Ownership
Private
Development stage
Phase 2
01

Overview

KoBioLabs develops functional probiotics and novel microbiome-based therapeutics. Its lead clinical candidate KBL‑697 has reached Phase II trials for plaque psoriasis. Other pipeline assets are at the preclinical stage targeting obesity, NASH, IBS, and immune-related diseases. The company also markets consumer probiotic products under brands such as Bioviom and Queens henna FOODOLOGY. It collaborates with partners like Celltrion on microbiome antibodies.

Therapeutic areas
GastroenterologyEndocrinologyDermatologyImmunology
Modalities
ProbioticsMicrobiota-based therapiesSmall molecule drugsChemical drugsAntibody (microbiome antibody)
Industry
Biotech
02

Drug pipeline

8 assets

Lactobacillus gasseri KBL697

2

7 more assets in the full pipeline.

Request access →
03

Partnerships

Collaboration with Celltrion on a microbiome antibody program targeting IBS.

Beyond the preview

Go deeper on KoBioLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KoBioLabs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call